Transcriptional silencing of the TFPI-2 gene by promoter hypermethylation in choriocarcinoma cells

Biological Chemistry

Volumn 384, Issue 7, 2003, Pages 1029-1034

  Hubé, Florent ^a   Reverdiau, Pascale ^a   Iochmann, Sophie ^a   Rollin, Jérôme ^a   Cherpi Antar, Catherine ^b   Gruel, Yves ^a  

^a Laboratoire d'Hémostase   (France)

^b INSERM   (France)

Author keywords

5 azapm deoxycytidine; JAR cells; Methylation status; Normal trophoblast cells; Tissue factor pathway inhibitor 2; Transcriptional silencing

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; BISULFITE; DNA; LUCIFERASE; PLACENTA PROTEIN 5; SERINE PROTEINASE INHIBITOR; TUMOR SUPPRESSOR PROTEIN;

ARTICLE; CANCER CELL CULTURE; CANCER INVASION; CHORIOCARCINOMA; CONTROLLED STUDY; CORRELATION ANALYSIS; CPG ISLAND; DEMETHYLATION; DNA METHYLATION; EXON; EXTRACELLULAR MATRIX; GENE FUNCTION; GENE SEQUENCE; GENE SILENCING; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IN VITRO STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN METHYLATION; TRANSCRIPTION INITIATION; TROPHOBLAST;

EID: 0042355175     PISSN: 14316730     EISSN: None     Source Type: Journal    
DOI: 10.1515/BC.2003.115     Document Type: Article

References (21)

1. Bergman, Y., and Mostoslavsky, R. (1998). DNA demethylation: turning genes on. Biol. Chem. 379, 401-407.
2. Christman, J.K. (2002). 5-Azacytidine and 5-aza-2′-deoxycytidine as inhibitors of DNA methylation: mechanistic studies and their implications for cancer therapy. Oncogene 21, 5483-5495.
3. Esteller, M. (2002). CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future. Oncogene 21, 5427-5440.
4. Frommer, M., McDonald, L.E., Millar, D.S., Collis, C.M., Watt, F., Grigg, G.W., Molloy, P.L., and Paul, C.L. (1992). A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands. Proc. Natl. Acad. Sci. USA 89, 1827-1831.
5. Guillaudeux, T., Rodriguez, A.M., Girr, M., Mallet, V., Ellis, S.A., Sargent, I.L., Fauchet, R., Alsat, E., and Le Bouteiller, P. (1995). Methylation status and transcriptional expression of the MHC class I loci in human trophoblast cells from term placenta. J. Immunol. 154, 3283-3299.
6. Hanski, C., Riede, E., Gratchev, A., Foss, H.D., Bohm, C., Klussmann, E., Hummel, M., Mann, B., Buhr, H.J., Stein, H., Kim, Y.S., Gum, J., and Riecken, E.O. (1997). MUC2 gene suppression in human colorectal carcinomas and their metastases: in vitro evidence of the modulatory role of DNA methylation. Lab. Invest. 77, 685-695.
7. Herman, M.P., Sukhova, G.K., Kisiel, W., Foster, D., Kehry, M.R., Libby, P., and Schonbeck, U. (2001). Tissue factor pathway inhibitor-2 is a novel inhibitor of matrix metalloproteinases with implications for atherosclerosis. J. Clin. Invest. 107, 1117-1126.
8. Hubé, F., Reverdiau, P., Iochmann, S., Trassard, S., Thibault, G., and Gruel, Y. (2003a). Demonstration of tissue factor pathway inhibitor-2 (TFPI-2) mRNA synthesis by pure villous cytotrophoblast cells isolated from term human placentas. Biol. Reprod. 68, 1888-1894.
9. Hubé, F., Reverdiau, P., Iochmann, S., Cherpi-Antar, C., and Gruel, Y. (2003b) Characterization and functional analysis of TFPI-2 gene promoter in a human choriocarcinoma cell line. Thromb. Res. 109, 207-215.
10. Iochmann, S., Reverdiau-Moalic, P., Hubé, F., Bardos, P., and Gruel, Y. (2002). Demonstration of inducible TFPI-2 mRNA synthesis in BeWo and JEG-3 trophoblast cells using a competitive RT-PCR. Thromb. Res. 105, 217-223.
11. Jin, M., Udagawa, K., Miyagi, E., Nakazawa, T., Hirahara, F., Yasumitsu, H., Miyazaki, K., Nagashima, Y., Aoki, I., and Miyagi, Y. (2001). Expression of serine proteinase inhibitor PP5/TFPI-2/MSPI decreases the invasive potential of human choriocarcinoma cells in vitro and in vivo. Gynecol. Oncol. 83, 325-333.
12. Kinoshita, H., Shi, Y., Sandefur, C., Meisner, L.F., Chang, C., Choon, A., Reznikoff, C.R., Bova, G.S., Friedl, A., and Jarrard, D.F. (2000). Methylation of the androgen receptor minimal promoter silences transcription in human prostate cancer. Cancer Res. 60, 3623-3630.
13. Konduri, S.D., Tasiou, A., Chandrasekar, N., Nicolson, G.L., and Rao, J.S. (2000). Role of tissue factor pathway inhibitor-2 (TFPI-2) in amelanotic melanoma (C-32) invasion. Clin. Exp. Metastasis 18, 303-308.
14. Konduri, S.D., Rao, C.N., Chandrasekar, N., Tasiou, A., Mohanam, S., Kin, Y., Lakka, S.S., Dinh, D., Olivero, W.C., Gujrati, M. et al. (2001). A novel function of tissue factor pathway inhibitor-2 (TFPI-2) in human glioma invasion. Oncogene 20, 6938-6945.
15. Lakka, S.S., Konduri, S.D., Mohanam, S., Nicolson, G.L., and Rao, J.S. (2000). In vitro modulation of human lung cancer cell line invasiveness by antisense cDNA of tissue factor pathway inhibitor-2. Clin. Exp. Metastasis 18, 239-244.
16. Miyagi, Y., Yasumitsu, H., Eki, T., Miyata, S., Kkawa, N., Hirahara, F., Aoki, I., Misugi, K., and Miyazaki, K. (1996). Assignment of the human PP5/TFPI-2 gene to 7q22 by FISH and PCR-based human/rodent cell hybrid mapping panel analysis. Genomics 35, 267-268.
17. Rao, C.N., Cook, B., Liu, Y., Chilukuri, K., Stack, M.S., Foster, D.C., Kisiel, W., and Woodley, D.T. (1998). HT-1080 fibrosarcoma cell matrix degradation and invasion are inhibited by the matrix-associated serine protease inhibitor TFPI-2/33 kDa MSPI. Int. J. Cancer 76, 749-756.
18. Rao, C.N., Mohanam, S., Puppala, A., and Rao, J.S. (1999). Regulation of ProMMP-1 and ProMMP-3 activation by tissue factor pathway inhibitor-2/matrix-associated serine protease inhibitor. Biochem. Biophys. Res. Commun. 255, 94-98.
19. Rao, C.N., Lakka, S.S., Kin, Y., Konduri, S.D., Fuller, G.N., Mohanam, S., and Rao, J.S. (2001). Expression of tissue factor pathway inhibitor 2 inversely correlates during the progression of human gliomas. Clin. Cancer Res. 7, 570-576.
20. Singal, R., Ferris, R., Little, J.A., Wang, S.Z., and Ginder, G.D. (1997). Methylation of the minimal promoter of an embryonic globin gene silences transcription in primary erythroid cells. Proc. Natl. Acad. Sci. USA 94, 13724-13729.
21. Sprecher, C.A., Kisiel, W., Mathewes, S., and Foster, D.C. (1994). Molecular cloning, expression, and partial characterization of a second human tissue-factor-pathway inhibitor. Proc. Natl. Acad. Sci. USA 91, 3353-3357.